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Opinion statement
Mitral valve disease represented by mitral stenosis and mitral regurgitation is the second
most frequent valvulopathy. Mitral stenosis leads to an increased left atrial pressure
whereas mitral regurgitation leads to an increased left atrial pressure associated with a
volume overload. Secondary to an upstream transmission of this overpressure, both mitral
stenosis and regurgitation lead to pulmonary hypertension and right heart failure. In
addition, mitral regurgitation also leads to left ventricular dilatation and dysfunction
with left heart failure. Depending on the anatomy of the valvular and subvalvular
apparatus, valve repair (percutaneous mitral commissurotomy for mitral stenosis and
valvuloplasty for mitral regurgitation) might be possible. If the anatomy is not favorable,
valve replacement by mechanical or biological prosthesis is indicated. Most of the
intervention indications are based on clinical symptoms and resting transthoracic echo-
cardiography. Outcomes of patients operated based upon resting echo abnormalities
might however not be optimal. Therefore early intervention might be beneficial based
upon abnormal exercise testing, which has been demonstrated to more sensitive to
identify high-risk patients. In this last decade, especially exercise echocardiography
has been found to be a crucial tool in the management of patients with mitral valve
disease.
Introduction
Mitral valvulopathy is composed by mitral stenosis
(MS) and primary/secondary mitral regurgitation (MR)
[1]. MS leads to an increase in left atrial pressure (LAP)
with an upstream transmission of this overpressure into
the pulmonary vascular bed eventually creating pulmo-
nary hypertension (PH). Primary or secondary MR also
leads to an upstream transmission of increased LAP and
to a left ventricular (LV) volume overload, which con-
tributes to LV dilatation and dysfunction. All these
changes in hemodynamic conditions contribute to the
onset of cardiovascular symptoms, which are closely
correlated to a poor outcome. Therefore, the occurrences
of cardiovascular symptoms or LV dysfunction are clear
indications for mitral valve surgery (valvular replace-
ment or valvuloplasty as appropriate) [1, 2••]. However,
some patients may underestimate their symptoms or
rapidly evolve from an asymptomatic state to LV dys-
function or resting PH. In this subset of patients, the
post-operative outcome may not be optimal.
The concept of exercise assessment of mitral
parameters and pulmonary hemodynamics has
emerged over the last decade with the aim to iden-
tify a subgroup of higher risk patients that may
benefit either from early elective surgery (even
without symptoms) or a close follow-up in a heart
valve clinic [3•, 4]. The goal of exercise evaluation
is to separate patients with an abnormal exercise
adaptation (abnormal increase in transmitral gradi-
ent for MS or abnormal increase in MR parameters
for primary MR or exercise-induced pulmonary hy-
pertension (EIPH) in secondary MR), whom are at
higher risk of post-operative LV dysfunction or per-
sistent PH.
The aim of this review is to highlight studies of
interest in the field of exercise echocardiography and
mitral valve disease and to highlight useful informa-
tion for the management of patients in daily clinical
practice.
Exercise echocardiography in normal subjects
Some prerequisites on exercise protocol and pulmonary circulation hemody-
namics in normal conditions are required for a complete understanding of
exercise echocardiography studies.
Normal adaption of the pulmonary circulatory system during exercise
There is a three- to fourfold increase in cardiac output (CO) secondary to
increased oxygen demand. The pulmonary vascular bed is a low resistance
high compliance system and has the ability to recruit and distend pulmo-
nary arterial vessels in response to the increase in flow and volume. This
leads to a drop in pulmonary vascular resistance (PVR) and only a mod-
erate increase in pulmonary arterial pressure (PAP) [5•]. Exercise pulmo-
nary arterial vasodilation has been demonstrated by La Gerche et al. [6].
Fourty athletes and 15 non-athletes were studied with exercise echocardi-
ography with pulmonary transit agitated contrast (PTAC) assessment at
peak exercise. At rest, PTAC was not present as pulmonary capillaries are
smaller than contrast bubbles. Patients were classified into high or low
PTAC, depending on the number of bubbles in the LV cavity. As compared
to low PTAC, patients with high PTAC demonstrated higher exercise CO
(16 ± 3 vs. 14 ± 3 L/min; p G 0.001), lower exercise systolic PAP (52 ± 10 vs.
63 ± 14 mmHg; p = 0.003), and lower exercise PVR (2.9 ± 1.0 vs. 4.6 ±
1.8 mmHg/L/min). These results suggested that recruitment of pulmonary
arterial vasodilatation results in a drop in PVR and a lower increase in PAP
during exercise.
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Protocol used for exercise echocardiography assessment
Exercise echocardiography is usually performed in a semi-supine position
allowing a good compromise between the feasibility of exercise and the ability
to acquire adequate quality echocardiography images during the exercise.
It is recommended to begin at 25 W and to increase the workload by 25 W
every 2 min until onset of symptoms, exhaustion, or achievement of the
maximal predicted heart rate.
Blood pressure, heart rate, and 12-lead electrocardiography are recorded at
rest and at each exercise level. Echocardiographic parameters (valvular param-
eters and sPAP) should be recorded at rest, at peak exercise, and during recovery.
If possible, recording these parameters during the exercise at each level may be
informative.
Exercise echocardiography assessment of PAP and PVR in healthy subjects
In the last few years, exercise echocardiography has been studied to understand
the adaptation of the vascular bed to exercise in healthy subjects [7, 8]. How-
ever, normal values of PAP during exercise should be considered carefully due
to confounding factors (i.e., age, CO, and exercise protocol).
Mahjoub et al. [9] demonstrated the age dependency of PAP in 70 healthy
volunteers. sPAP, as assessed by echocardiography, increased from 27 ± 4 to 34
± 6 mmHg at 25 W and to 51 ± 9 mmHg at peak exercise. Older patients
(960 years) presented with a higher exercise sPAP (56 ± 9mmHg) than younger
patients (49 ± 7 mmHg, p = 0.02). In addition, 36% of 60 to 70 years patients
presented a peak exercise sPAP ≥60 mmHg, so as 50% of subjects older than
70 years. Thus, exercise sPAP is related to age and the cutoff value of 60 mmHg
at peak exercise should be interpreted with caution, depending on age.
Argiento et al. [8] studied the feasibility of exercise PAP assessment by
echocardiography and confirmed the age and gender dependency of PAP in
124 healthy subjects. Eleven individuals were excluded due to insufficient
quality of echocardiographic images. The final study group included 57 women
and 56men aged from19 to 63 years. The average slope ofmPAP-COwas 1.5 ±
0.5 mmHg/L/min (normal range from 0.5 to 2.5 mmHg/L/min) and the
distensibility coefficient α was 1.3 ± 1%mmHg−1. Consistently with right heart
catheterization (RHC) studies, upper limits of normal values of mPAP at
exercise would be 34 mmHg at a CO G10 L/min, 45 mmHg between 10 and
20 L/min, and 52 mmHg for CO 930 L/min. Finally, there were differences
regarding age and gender. At peak exercise, men achieved higher workload
(153 ± 34 vs. 198 ± 54 W; p G 0.001), CO (15 ± 3 vs. 21 ± 4 L/min; p
G 0.001), mPAP (31 ± 7 vs. 36 ± 6 mmHg; p G 0.001), and PVR (1.4 ± 0.4
vs. 1.3 ± 0.3 Woods units; p G 0.05). There was no gender difference for
exercise LAP (10 ± 1 vs. 10 ± 1 mmHg) and indexed PVR (2.4 ± 0.8 vs. 2.5
± 0.6 Woods units/m2). α coefficient was higher in women at peak exercise
(1.4 ± 1.1 vs. 0.9 ± 0.4% mmHg−1; p G 0.01).
Therefore, it is now well accepted that the normal value of the slope
mPAP-CO is smaller than 3 mmHg/L/min or sPAP G50 mmHg if CO is
under 10 L/min.
Age and flow adjustment should be integrated in results interpretation
(integration of LVCO in the interpretation of sPAP or assess the slope of
PAP-CO).
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Mitral stenosis
With decline of rheumatic fever in developed countries, the incidence and preva-
lence of rheumatic MS have clearly decreased over the last decades. Worldwide
however,MS remains present in daily practice and is clearly linked to an increase in
morbidity and mortality [1]. At the beginning of the disease, patients remain
asymptomatic with a good outcome. At end stage disease, the onset of atrial
fibrillation, thromboembolism, heart failure, and PH is associated with a de-
creased survival. Transition between these two stages may be rapid. The treatment
of MS is either percutaneous mitral comissurotomy (PMC) or valve replacement
depending on the valve characteristics and patients’ profile and comorbidity [10].
Classical indications for PMC are as follows:
– Symptomatic patients without unfavorable characteristics (old age, previ-
ous commissurotomy, NYHA class IV, permanent atrial fibrillation, severe
PH, Echo score 98, Cormier score 3, very small mitral valve area, severe
tricuspid regurgitation) (class I B),
– Symptomatic patients with contraindication or high risk for surgery (class I C),
– Asymptomatic patients without unfavorable characteristics and high
thromboembolic risk and/or high risk of hemodynamic decompensation
(sPAP 950 mmHg at rest) (class II A) [1].
Mitral valve replacement is considered for the same conditions in
patients not suitable for PMC.
Exercise echocardiography in mitral stenosis
There are few data on exercise assessment in MS patients. In this particular
condition, both dobutamine stress (DSE) and exercise echocardiography have
been explored and compared [11]. Even though exercise assessment is clearly
more physiologic, DSE may also be performed in patients with MS.
DSE has been shown to be a useful tool to identify patients with a worse
outcome. Reis et al. [12] included 53 patients with moderate to severe MS and
performed a DSE in all patients. After a mean follow-up of 60 months, 29
patients presented with cardiovascular complications. In a multivariable anal-
ysis, the increase of mean transmitral gradient (MTMG) was the best predictor
of adverse events with a cutoff value of 18 mmHg. Finally, the authors con-
cluded that, in addition to conventional management, DSE might increase the
detection of high-risk patients presenting moderate mitral stenosis. More re-
cently, Brochet et al. [13] explored 48 “asymptomatic” patients presenting
moderate to severe MS. Exercise echocardiography allowed identification of
patients who underestimated their symptoms, since 46% of them described
dyspnea during test. Interestingly, there were no significant differences between
patients with or without exercise dyspnea regarding resting or exercise MS
severity and PAP. However, patients with dyspnea exhibited a more rapid
increase in exercise PAP. Thus, the cutoff value of sPAP 960 mmHg at exercise
did not discriminate “false asymptomatic” patients but an early increase in
relative sPAP 990% at 60 W revealed an abnormal risk of developing dyspnea
or requiring valvular intervention during follow-up (Fig. 1).
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Finally, atrioventricular compliance seems to play an important role in the
increase of PAP during exercise in patients with MS [14, 15] and may be
integrated in the interpretation of exercise echocardiography in MS patients.
Reasonably, it has been demonstrated that patients with a low atrioventricular
compliance (≤4 mL/mmHg) had greater increase in exercise PAP, which was
correlated to dyspnea. In addition, this parameter was directly linked to a
decrease in functional capacity.
Therefore, exercise echocardiography has been integrated in the latest Amer-
ican guidelines [2••], PMCmay be consideredwhen valve anatomy is suitable, in
patients with mild-moderate MS (mitral valve area (MVA) 91.5 cm2) and abnor-
mal increase in MTMG 915 mmHg during exercise (class II b). It has been
proposed to closely follow-up patients without any symptoms and presenting
significantMS (MVA G1.5 cm2) associatedwith EIPH (960mmHg) or an increase
in MTMG 915 mmHg [4] (resting and exercise key values listed in Table 1).
Fig. 1. Exercise echocardiography in a 58-year-old women with moderate mitral stenosis and exercise dyspnea. a Resting mean
transmitral gradient (MTMG) showing moderate mitral stenosis (mean gradient 6 mmHg and mitral area estimated at 1.6 cm2). b
Resting systolic pulmonary arterial pressure (sPAP) assessed by transtricuspid gradient (probably underestimated due to very mild
tricuspid regurgitation at rest) and right atrial pressure. c Exercise transmitral gradient showing a significant increase in mean
gradient at peak exercise. Patient presented with dyspnea with limited exercise workload (75 W). d Exercise sPAP showing an
abnormal increase in sPAP (960 mmHg) and in slope of PAP-CO (93 mmHg/L/min).
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Primary mitral regurgitation
Degenerative MR is the second most frequent valvular heart disease in Europe
[1]. MR results in an increased LA pressure and an upstream transmission of
pressure to pulmonary vascular bed. Chronic PAP elevation may lead to defin-
itive remodeling of pulmonary vessels and increase post-operative mortality. In
acute MR, mainly represented by chordal rupture or papillary muscle rupture,
the indication of surgery is not debated as the acute volume and pressure
overload is always poorly tolerated and related to a poor outcome. In chronic
primary MR, surgery is currently indicated in the following:
– Symptomatic patients with LV ejection fraction (LVEF) 930% and LV end-
systolic diameter (ESD) G55 mm (class I)
– Asymptomatic patients with LV dysfunction (G60%) and/or LV dilatation
(ESD 945 mm) (class I).
Mitral surgery should also be considered in the following:
– Asymptomatic patients with onset of atrial fibrillation or resting PH (PAP
950 mmHg) or with flail leaflet and suitable for a valve repair and with
LVESD 940 mm (class IIa)
– In patients with severe LV dysfunction (G30%), LV dilatation (LVESD
955 mm) refractory to medical therapy, surgery should be discussed if
there is a high likelihood of durable repair (class IIa) or a low likelihood of
durable repair (class IIb).
Surgical indications are no longer questioned in symptomatic patients
or in patients with LV dysfunction and/or dilatation or with resting PH,
but the role of early/preemptive surgery in asymptomatic patients with
high-risk profile is more controversial and has been debated in the last few
years.
Exercise echocardiography in primary mitral regurgitation
Exercise echocardiography has been proposed as a useful method to identify
patients at higher risk who may beneficiate from an early elective surgery.
Magne et al. [16] performed a comprehensive resting and exercise echocardiog-
raphy study in 78 patients (age 61 ± 13 years, 56% men) with moderate to
severe degenerative MR. Resting PH and EIPH were defined as previously
Table 1. Key values in mitral stenosis and level of recommendation for treatment
Parameters Key value Level Guidelines
Mitral valve area ≤1.5 cm2 European
Resting MTMG 910 mmHg European
Resting sPAP 950 mmHg IIa European
Exercise increase in MTMG 915 mmHg IIb American
MTMG mean transmitral gradient, sPAP systolic pulmonary arterial pressure
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described in the guidelines [1]. EIPH was present in 46% of study patients.
Patients with EIPH had more severe MR at peak exercise (higher exercise
effective regurgitant orifice (ERO) area and regurgitant volume (RV)). Age,
resting sPAP, and exercise MR parameters were associated with EIPH. After a
mean follow-up of 19 ± 14 months, 49% patients developed symptoms. Pa-
tients who developed symptoms had higher resting-to-exercise changes in
effective regurgitant orifice and regurgitant volume. Patients with EIPH had
lower rate of symptom-free survival at 1 and 2 years. EIPH remained signifi-
cantly associatedwith symptom-free survival regardless of the statisticalmethod
of analysis (adjustment for age, sex, resting, and exercise data). A peak exercise
sPAP 956 mmHg was the best cutoff to predict the onset of symptoms (spec-
ificity 73% and sensibility 82%). Exercise echocardiography in primary MR
allows a better understanding of the pathophysiology of the valvularmechanics
at exercise and its consequences on pulmonary hemodynamics. Patients with
greater MR at exercise and thus higher sPAP are at higher risk of cardiovascular
events during follow-up. Therefore, a early/preemptive surgery has been pro-
posed for this specific subgroup [1].
More recently, Kusunose et al. [17] have studied exercise RV function in
addition to exercise sPAP, as a predictive parameter of event-free survival in
patients with primary MR. They studied 196 patients at rest and during exercise.
They defined four groups depending on the median of exercise sPAP
(54 mmHg) and exercise TAPSE (19 mm). They showed that patients with
EIPH (exercise sPAP 954 mmHg) but no exercise RV dysfunction (TAPSE
919mm) had a better 4-year event-free survival (71%) than patients with EIPH
and RV dysfunction (25%). These results suggest that there is probably a
continuum of the valvular consequences on the pulmonary vasculature and
that EIPHmay lead to exercise RV dysfunction corresponding to patients with a
very high risk in the subgroup of EIPH patients.
Finally, the presence of pre-operative EIPH has been correlated with an
increased risk of cardiac events in the post-operative period (19). Magne et al.
[18•] studied 102 patients with primary MR, NYHA ≤2, no LV dysfunction,
and/or dilatation. All patients underwent comprehensive exercise echocardiog-
raphy and were followed prospectively. Baseline EIPH was defined as a peak
exercise sPAP 960 mmHg. Surgery was indicated based on the current guide-
lines. After a mean follow-up of 50 months, 26% of patients presented cardiac
events. Patients with EIPH at baseline had higher post-operative complications
(39 vs. 12%, p G 0.05). This was confirmed even after exclusion of atrial fibril-
lation criteria (39 vs. 9%, p G 0.05). Event-free survival was lower in patients
presenting baseline EIPH (60 ± 8 vs. 88 ± 5%, p = 0.007). After Cox multivariate
analysis, EIPH remained significantly associated with onset of post-operative
cardiac complications (resting and exercise key values listed in Table 2).
Secondary mitral regurgitation
Secondary or “functional” MR represents a complex situation where LV
dysfunction/dilatation directly impacts the functioning of the subvalvular and
valvular apparatus. Two different situationsmay be encountered. The first one is
transient myocardial ischemia of the inferolateral myocardial wall and/or pap-
illary muscle leading to MR increase during exercise, usually revealing a
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coronary artery disease. The second one is represented by a chronic ischemic or
non-ischemic cardiomyopathy leading to LV remodeling with a mitral annulus
dilatation and tethering of the subvalvular apparatus. Chronic secondary MR is
related to increased morbidity and mortality, and surgery is currently indicated
in the following:
– Patients with severe MR undergoing coronary artery bypass graft (CABG)
and LVEF 930% (class I),
– Patients with moderate MR undergoing CABG, especially in case of dys-
pnea and abnormal MR severity increase with exercise (class IIa),
– Symptomatic patients with severe MR, LVEF G30%, option for revascu-
larization, and evidence of myocardial viability (class IIa),
– Patients with severe MR, LVEF 930%, who remain symptomatic despite
optimal medical management (including cardiac resynchronization ther-
apy if indicated) and have low comorbidity, when revascularization is not
indicated (class IIb)
The inbalance between leaflet tethering and closing forces which is
exaggerated during exercise by increased LV filling pressure can lead to an
acute chronic increase of significant secondary MR consequently resulting
in EIPH, which is associated with a worse prognosis [19–21].
Therefore, exercise echocardiography is actually suggested [1] in case of
LV dysfunction associated with the following situations: dyspnea during
exercise out of proportion with resting MR severity and LV dysfunction,
acute pulmonary edema without obvious causes, moderate secondary MR
before surgical revascularization, and risk stratification of mortality in
heart failure patients.
Exercise echocardiography and secondary mitral regurgitation
It has been demonstrated that resting echocardiography cannot predict the
severity of MR during exercise [22]. Lancellotti et al. [22] studied 70 patients
Table 2. Key values in degenerative mitral regurgitation and level of recommendation for treatment
Parameters Cutoff Level Guidelines
EROA ≥40 mm2 European
RV ≥60 mL European
LVEF 930 G 60% I European
LVESD ≥45 G 55 mm I European
LVESD ≥40 mm with flail leaflet IIa European
Resting sPAP 950 mmHg IIa European
Left atrial volume ≥60 mL/m2 IIb European
Exercise sPAP ≥60 mmHg IIb European
EROA effective regurgitant orifice area, RV regurgitant volume, LVEF left ventricular ejection fraction, LVESD left ventricular end-systolic
diameter, sPAP systolic pulmonary arterial pressure
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with at least moderate secondary MR and LV systolic dysfunction (EF G45%).
All patients underwent an exercise echocardiography and predictors of exercise-
induced change in MR parameters were evaluated. Resting echocardiographic
parameters of MR did not correlate with exercise-induced change in EROA.
Predictors of abnormal increase in exercise ERO were changes in systolic annu-
lar area for all infarct categories, in tenting area and wall motion score in the
global population and those with inferior infarction, and in apical displace-
ment of mitral leaflets for patients with anterior myocardial infarction (MI).
Piérard and Lancellotti [21] also demonstrated the clinical impact of dy-
namic MR in patients with post MI LV dysfunction. Compared to patients who
did not experience pulmonary edema, patients presenting with recent pulmo-
nary edema exhibited at peak exercise, a lower increase in LVEF, a greater
increasing in tenting area, in EROA (16 ± 10 vs. 2 ± 9 mm2, p G 0.001) and
regurgitant volume (RV) (26 ± 14 vs. 5 ± 14 mL, p G 0.001), and in PAP (29 ±
10 vs. 13 ± 11 mmHg, p G 0.001). Of note, there were no significant differences
for demographic parameters and resting echocardiographic data. Finally, in a
multivariable analysis, exercise-induced changes in the EROA, in PAP, and in
LVEF were independently associated with a history of recent pulmonary edema.
Finally, Lancellotti et al. [23] later confirmed these results. They prospective-
ly enrolled 161 patients with chronic ischemic cardiomyopathy, LV dysfunc-
tion, and at leastmoderate secondaryMR. After amean follow-upof 35months,
20 patients had cardiac surgery, 23 died, 22 were hospitalized for heart failure,
and 15 had acute coronary syndromes. In a multivariable analysis, best predic-
tors for mortality and heart failure were an increase during exercise ≥13mm2 in
EROA and a greater increase in PAP. Resting MR severity was only predictor of
cardiac death.
Therefore, the latest European guidelines [1] recommend mitral surgery in
patients with moderate MR undergoing CABG, especially in case of exercise
dyspnea and abnormal increase in MR severity during exercise (class IIa)
(resting and exercise key values listed in Table 3).
Conclusion
Exercise assessment in mitral valve disease clearly offers useful information in
terms of understanding the pathophysiology, individual risk stratification, and
patient management.
Table 3. Key values in functional regurgitation and level of recommendation for treatment
Parameters Cutoff Level Guidelines
EROA ≥20 mm2 European
RV ≥30 mL European
LVEF 930% and CABG I European
LVEF G30% with viability and revascularization IIa European
Exercise increase in EROA Moderate MR and CABG IIa European
CABG coronary artery bypass grafting, EROA indicates effective regurgitant orifice area, RV regurgitant volume, LVEF left ventricular ejection
fraction, MR mitral regurgitation
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In primary mitral regurgitation, the place of exercise echocardiographic
assessment is now clearly defined, and surgery is indicated when an abnormal
increase in PAP during exercise occurs in asymptomatic patients.
In secondary mitral regurgitation, exercise echocardiography has been iden-
tified as a very interesting tool, especially for risk stratification. However, due to
the complexity of the disease, its place to define the indication and the timing of
surgery remains debated.
In mitral stenosis, exercise stress echocardiography may be interesting in a
defined subset of patients, and is integrated in the management of MS patients
in the American guidelines.
Further prospective studies are clearly needed to further define the role of
exercise echocardiography in the management of patients presenting with
secondary mitral regurgitation and mitral stenosis.
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